| CDOAX | VVIAX | CDOAX / VVIAX | |
| Total Expense Ratio | 0.78 | 0.05 | 1,560% |
| Annual Report Gross Expense Ratio | 0.78 | 0.05 | 1,560% |
| Fund Existence | 2 years | 26 years | - |
| Gain YTD | 19.850 | 18.454 | 108% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.63B | 256B | 1% |
| Annual Yield % from dividends | 2.34 | 1.85 | 127% |
| Returns for 1 year | 21.48 | 25.22 | 85% |
| Returns for 3 years | N/A | 56.02 | - |
| Returns for 5 years | N/A | 59.62 | - |
| Returns for 10 years | N/A | 157.51 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISCV | 81.62 | 0.44 | +0.54% |
| iShares Morningstar Small-Cap Value ETF | |||
| ALRG | 31.69 | N/A | N/A |
| Allspring LT Large Core ETF | |||
| FTMS | 9.90 | N/A | N/A |
| Franklin Short-Term Municipal Income ETF | |||
| RSBA | 20.71 | -0.01 | -0.05% |
| Return Stacked Bonds & Mrg Arbtrg ETF | |||
| XBI | 156.86 | -2.53 | -1.59% |
| State Street® SPDR® S&P® Biotech ETF | |||